Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Cytomegalovirus

M A Smith1, D J Brennessel

  • 1Long Island Jewish Medical Center, Albert Einstein College of Medicine, New Hyde Park, New York.

Infectious Disease Clinics of North America
|June 1, 1994
PubMed
Summary
This summary is machine-generated.

Cytomegalovirus (CMV) is a significant opportunistic pathogen in AIDS patients, causing major illness. Research is exploring new treatments and vaccines to control CMV infection in this vulnerable population.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Contaminated stethoscopes revisited.

Archives of internal medicine·1996
Same author

Regulation of corticotropin-releasing hormone receptor messenger ribonucleic acid in the rat brain and pituitary by glucocorticoids and stress.

Endocrinology·1995
Same author

Stress and antidepressants differentially regulate neurotrophin 3 mRNA expression in the locus coeruleus.

Proceedings of the National Academy of Sciences of the United States of America·1995
Same author

Induction of heme oxygenase-1 mRNA and protein in neocortex and cerebral vessels in Alzheimer's disease.

Journal of neurochemistry·1995
Same author

Stress increases brain-derived neurotropic factor messenger ribonucleic acid in the hypothalamus and pituitary.

Endocrinology·1995
Same author

The future of procedural training in family practice residency programs: look before you LEEP.

Family medicine·1995
Same journal

Prevention and Control of Clostridioides difficile Infection for the Infectious Diseases Clinician.

Infectious disease clinics of North America·2026
Same journal

Infection Control Strategies to Prevent Emergence and Transmission of Resistant Gram-Negative Bacteria.

Infectious disease clinics of North America·2026
Same journal

Preventing the Spread of Tuberculosis in Health Care Settings.

Infectious disease clinics of North America·2026
Same journal

Threats to Success: Principles of Infection Prevention and Control in Health Care Settings, Part 2: Device and Pathogen Management.

Infectious disease clinics of North America·2026
Same journal

Ventilator-Associated Events: Surveillance and Prevention.

Infectious disease clinics of North America·2026
Same journal

Nosocomial Fungal Infections: Epidemiology, Control Strategies, and Prevention of Candida and Other Yeasts.

Infectious disease clinics of North America·2026
See all related articles

Area of Science:

  • Infectious Diseases
  • Virology
  • Immunocompromised Hosts

Background:

  • Cytomegalovirus (CMV) is a common opportunistic pathogen in patients with Acquired Immunodeficiency Syndrome (AIDS).
  • CMV is a known cause of increased mortality in immunosuppressed patients without AIDS.
  • The direct contribution of CMV to mortality in AIDS patients remains a subject of debate.

Purpose of the Study:

  • To review the major clinical syndromes associated with CMV infection.
  • To discuss ongoing research into optimal antiviral treatment strategies for CMV in AIDS patients.
  • To highlight the investigation of novel drugs and vaccines for CMV control.

Main Methods:

  • Literature review focusing on clinical syndromes of CMV infection.
  • Analysis of studies on antiviral regimens and emerging therapies.

Related Experiment Videos

  • Examination of research on vaccine development for CMV prevention.

    • Main Results:

    • CMV infection presents significant morbidity in the AIDS population.
    • Optimal dosing and combination antiviral regimens are under investigation.
    • New drugs and vaccines are being developed to manage CMV in AIDS patients.

    Conclusions:

    • CMV infection poses a major health challenge for individuals with AIDS.
    • Further research is crucial for developing effective treatments and preventative measures.
    • The goal is to better control and potentially eliminate CMV infection in AIDS patients.